[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Idexx Laboratories (IDXX)

Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 46,005,344
  • Shares Outstanding, K 79,425
  • Annual Sales, $ 4,304 M
  • Annual Income, $ 1,059 M
  • EBIT $ 1,360 M
  • EBITDA $ 1,505 M
  • 60-Month Beta 1.58
  • Price/Sales 10.39
  • Price/Cash Flow 37.32
  • Price/Book 28.73

Options Overview Details

View History
  • Implied Volatility 32.13% (+0.99%)
  • Historical Volatility 29.16%
  • IV Percentile 56%
  • IV Rank 39.59%
  • IV High 49.02% on 01/30/26
  • IV Low 21.07% on 08/12/25
  • Expected Move (DTE 8) 21.75 (3.82%)
  • Put/Call Vol Ratio 7.50
  • Today's Volume 17
  • Volume Avg (30-Day) 90
  • Put/Call OI Ratio 0.61
  • Today's Open Interest 2,155
  • Open Int (30-Day) 2,232
  • Expected Range 547.68 to 591.18

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $3.94
  • Number of Estimates 7
  • High Estimate $4.04
  • Low Estimate $3.83
  • Prior Year $3.63
  • Growth Rate Est. (year over year) +8.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
544.01 +5.02%
on 04/29/26
605.82 -5.69%
on 04/08/26
-3.46 (-0.60%)
since 04/07/26
3-Month
544.01 +5.02%
on 04/29/26
666.14 -14.23%
on 02/26/26
-73.27 (-11.37%)
since 02/06/26
52-Week
485.40 +17.70%
on 05/08/25
769.98 -25.80%
on 11/26/25
+84.73 (+17.41%)
since 05/07/25

Most Recent Stories

More News
Idexx: Q1 Earnings Snapshot

Idexx: Q1 Earnings Snapshot

IDXX : 575.35 (-0.67%)
IDEXX Laboratories Announces First Quarter Results

Achieves first quarter revenue growth of 14% as reported and 11% organic, and CAG Diagnostics recurring revenue growth of 14% as reported and 11% organic. ...

IDXX : 575.35 (-0.67%)
IDEXX Laboratories Set to Reveal Whether Veterinary Diagnostics Momentum Can Justify Premium Valuation

Barchart Research What to Expect from IDXX Earnings IDXX Generated May 4, 2026 Current Price $563.12 EPS Estimate $$3.42 Consensus Rating Moderate Buy Average Move 10.62% IDEXX Laboratories Set to Reveal...

IDXX : 575.35 (-0.67%)
What You Need to Know Ahead of IDEXX Laboratories' Earnings Release

IDEXX Laboratories is ready to release its fiscal first-quarter earnings next month, and analysts project a double-digit profit growth.

XLV : 144.56 (-0.58%)
$SPX : 7,355.18 (-0.13%)
IDXX : 575.35 (-0.67%)
IDEXX Laboratories to Release 2026 First Quarter Financial Results

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2026 first quarter financial results for Tuesday, May 5, 2026, before the...

IDXX : 575.35 (-0.67%)
IDEXX Announces UK Availability of Cancer Dx Panel for Early Detection of Canine Lymphoma

Helping clinicians investigate sooner and plan next steps with confidence

IDXX : 575.35 (-0.67%)
Is IDEXX Laboratories Stock Outperforming the S&P 500?

Despite outperforming the broader S&P 500 Index over the past year, analysts maintain a cautiously optimistic outlook on IDEXX Laboratories’ future prospects.

$SPX : 7,355.18 (-0.13%)
ZTS : 89.11 (-19.88%)
IDXX : 575.35 (-0.67%)
How Is Thermo Fisher Scientific’s Stock Performance Compared to Other Medical Devices Stocks?

Although Thermo Fisher Scientific stock has declined over the past year, it has slightly outperformed other medical device stocks, and analysts remain highly bullish about its prospects.

TMO : 471.91 (-0.22%)
IDXX : 575.35 (-0.67%)
IHI : 50.36 (+1.31%)
Are Wall Street Analysts Bullish on IDEXX Laboratories Stock?

IDEXX Laboratories has outperformed the broader market over the past year, and analysts remain moderately bullish about the stock’s prospects.

XLV : 144.56 (-0.58%)
$SPX : 7,355.18 (-0.13%)
IDXX : 575.35 (-0.67%)
IDEXX Laboratories to Present at Two Institutional Investor Conferences

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming conferences: Thursday, February...

IDXX : 575.35 (-0.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care...

See More

Key Turning Points

3rd Resistance Point 619.97
2nd Resistance Point 600.31
1st Resistance Point 589.77
Last Price 575.35
1st Support Level 559.57
2nd Support Level 539.91
3rd Support Level 529.37

See More

52-Week High 769.98
Fibonacci 61.8% 661.27
Fibonacci 50% 627.69
Fibonacci 38.2% 594.11
Last Price 575.35
52-Week Low 485.40

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.